Sponsor Dossier
A Menarini
Sponsor Dossier for A Menarini. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ABSTRAL
- Brand: ADENURIC
- Brand: ALLERTINE
- Brand: BRETARIS
- Brand: BRIMICA
- Brand: CRESTOR
- Brand: LOBIVON
- Brand: MONOFER
- Device (sponsor): Non-sterile scar management dressing, reusable
About
A Menarini is an Australian Private Company with ABN 62116935758, registered in NSW and currently active.
Portfolio
A Menarini has 16 brands on the ARTG, with 13 indexable brands and 12 brands with Product Information on file. Five brands in the portfolio are PBS-listed, eight have PBAC outcomes on record, and six have AusPARs on record. Notable brands include ABSTRAL, ADENURIC, ALLERTINE, BRETARIS, BRIMICA, CRESTOR, LOBIVON, MONOFER, NEBILET, ORFADIN, ORSERDU, and PRILIGY.
Therapeutic focus —
Cardiology: 3 brands — Urology: 3 brands — Respiratory: 2 brands — Oncology: 2 brands — Neurology: 1 brand — Haematology: 1 brand — Rare Disease: 1 brand — Immunology: 1 brand — Complementary Medicine: 1 brand — Dermatology: 1 brand
PBS footprint
Five brands in the portfolio are PBS-listed, with the latest PBS schedule date touched on 2026-05-01.
Regulatory activity
The latest PBAC outcome for A Menarini was recorded on 2025-07-01 across eight brands with PBAC outcomes on record. The most recent AusPAR was issued on 2016-05-12 for six brands with AusPARs on record.